Linda Stacy - National Research Principal Officer
| NRC Stock | USD 18.75 0.08 0.42% |
Executive
Linda Stacy is Principal Officer of National Research Corp
| Phone | 402 475 2525 |
| Web | https://www.nrchealth.com |
Linda Stacy Latest Insider Activity
Tracking and analyzing the buying and selling activities of Linda Stacy against National Research stock is an integral part of due diligence when investing in National Research. Linda Stacy insider activity provides valuable insight into whether National Research is net buyers or sellers over its current business cycle. Note, National Research insiders must abide by specific rules, including filing SEC forms every time they buy or sell National Research'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Linda Stacy over six months ago Insider Trading |
National Research Management Efficiency
The company has Return on Asset of 0.1853 % which means that on every $100 spent on assets, it made $0.1853 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5856 %, implying that it generated $0.5856 on every 100 dollars invested. National Research's management efficiency ratios could be used to measure how well National Research manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Latosha CPA | Northrim BanCorp | 45 | |
| Patrick Duncan | NI Holdings | 57 | |
| Kyle Reeb | PC Connection | N/A | |
| Scott Sova | PC Connection | N/A | |
| Brian Hicks | PC Connection | N/A | |
| Amber Zins | Northrim BanCorp | 42 | |
| Nathan Reed | Northrim BanCorp | N/A | |
| Jason Criqui | Northrim BanCorp | N/A | |
| William Thompson | NI Holdings | N/A | |
| Cameron Kelly | PC Connection | N/A | |
| Lynn Wolfe | Northrim BanCorp | N/A | |
| Jay JD | PC Connection | 67 | |
| Timothy Scanlan | Omega Flex | 68 | |
| Joan Evans | PC Connection | N/A | |
| Michael Baldwin | Northrim BanCorp | 57 | |
| Timothy CPA | NI Holdings | 59 | |
Management Performance
| Return On Equity | 0.59 | ||||
| Return On Asset | 0.19 |
National Research Corp Leadership Team
Elected by the shareholders, the National Research's board of directors comprises two types of representatives: National Research inside directors who are chosen from within the company, and outside directors, selected externally and held independent of National. The board's role is to monitor National Research's management team and ensure that shareholders' interests are well served. National Research's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, National Research's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, CFO, Fin | ||
| Jennifer Baron, Chief Officer | ||
| Gregory MS, Chief Officer | ||
| Linda Stacy, Principal Officer | ||
| Jona Raasch, Chief Officer | ||
| Jon Boumstein, Chief Officer | ||
| Michael Hays, CEO, Director | ||
| Helen Hrdy, Chief Officer | ||
| Megan Charko, Senior Marketing | ||
| Andy Monnich, Chief Officer | ||
| Kevin CPA, CFO, Finance | ||
| Jason Hahn, Chief Officer | ||
| Vinitha Ramnathan, Chief Officer | ||
| Christophe Louvion, Chief Officer |
National Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is National Research a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.59 | ||||
| Return On Asset | 0.19 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 490.35 M | ||||
| Shares Outstanding | 23.48 M | ||||
| Shares Owned By Insiders | 37.30 % | ||||
| Shares Owned By Institutions | 52.07 % | ||||
| Number Of Shares Shorted | 341.73 K | ||||
| Price To Earning | 26.72 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Business Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.